Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade.

Andreas SøborgJoanne ReekieHenrik SengeløvCaspar Da Cunha-BangThomas Kromann LundChristina EkenbergIsabelle Paula LoddingKasper Sommerlund MoestrupLouise LundgrenJens D LundgrenNeval Ete Wareham

Published in: European journal of haematology (2024)

As risk of all-cause mortality and death from GvHD decreases, death from relapse remains the greatest obstacle in further improvement of survival after HCT.

Keyphrases

bone marrow
stem cell transplantation
single cell
cell therapy
stem cells
low dose
allogeneic hematopoietic stem cell transplantation
cell death